Literature DB >> 21526050

Molecular biology of heart disease.

Robert Roberts1.   

Abstract

Dr. Robert Roberts is currently Professor of Medicine and Director of the Ruddy Canadian Cardiovascular Genetics Centre along with being President and CEO of the University of Ottawa Heart Institute. Prior to this appointment, he was Chief of Cardiology for 23 years at Baylor College of Medicine, Houston, Texas. His original research was in cardiac enzymology which led to the development of the MBCK test which was the standard diagnostic assay for myocardial infarction for more than 3 decades. In the late 1970s, his research interests switched to molecular biology and the genetics of cardiomyopathies. He is regarded as one of the founders of molecular cardiology and has identified and sequenced more than 20 genes responsible for cardiovascular disorders. In the past 6 years, he has pursued genome-wide association studies to identify genes predisposing to coronary artery disease (CAD) and myocardial infarction. The first genetic variant for CAD, 9p21, was identified by Dr. Robert's laboratory and, in collaboration with the international consortium, CARDIoGRAM, has identified 13 novel genes for CAD.

Entities:  

Keywords:  Creatine kinase; Genetic linkage; Genetics; Genome wide association studies; Heart disease; Molecular biology

Year:  2011        PMID: 21526050      PMCID: PMC3082736          DOI: 10.4330/wjc.v3.i4.121

Source DB:  PubMed          Journal:  World J Cardiol


  78 in total

Review 1.  Genome-wide association studies of hypertension: have they been fruitful?

Authors:  Sajjad Rafiq; Sonia Anand; Robert Roberts
Journal:  J Cardiovasc Transl Res       Date:  2010-03-30       Impact factor: 4.132

2.  Serial Alu sequence transposition interrupting a human B creatine kinase pseudogene.

Authors:  T S Ma; J Ifegwu; L Watts; M J Siciliano; R Roberts; M B Perryman
Journal:  Genomics       Date:  1991-06       Impact factor: 5.736

3.  Isolation of a human chromosome 14-only somatic cell hybrid: analysis using Alu and LINE-based PCR.

Authors:  A Mares; S A Ledbetter; D H Ledbetter; R Roberts; J F Hejtmancik
Journal:  Genomics       Date:  1991-09       Impact factor: 5.736

4.  Genomic organization and isoform-specific tissue expression of human NAPOR (CUGBP2) as a candidate gene for familial arrhythmogenic right ventricular dysplasia.

Authors:  D Li; L L Bachinski; R Roberts
Journal:  Genomics       Date:  2001-06-15       Impact factor: 5.736

5.  Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.

Authors:  M H Gollob; M S Green; A S Tang; T Gollob; A Karibe; A S Ali Hassan ; F Ahmad; R Lozado; G Shah; L Fananapazir; L L Bachinski; R Roberts; A S Hassan
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

6.  An improved basis for enzymatic estimation of infarct size.

Authors:  R Roberts; P D Henry; B E Sobel
Journal:  Circulation       Date:  1975-11       Impact factor: 29.690

7.  Human eHAND, but not dHAND, is down-regulated in cardiomyopathies.

Authors:  A Natarajan; H Yamagishi; F Ahmad; D Li; R Roberts; R Matsuoka; S Hill; D Srivastava
Journal:  J Mol Cell Cardiol       Date:  2001-09       Impact factor: 5.000

8.  Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.

Authors:  M A Sloan; T R Price; C K Petito; A M Randall; R E Solomon; M L Terrin; J Gore; D Collen; N Kleiman; F Feit
Journal:  Neurology       Date:  1995-04       Impact factor: 9.910

9.  Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.

Authors:  R Anan; G Greve; L Thierfelder; H Watkins; W J McKenna; S Solomon; C Vecchio; H Shono; S Nakao; H Tanaka
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

10.  Isolation and sequence analysis of a full-length cDNA for human M creatine kinase.

Authors:  M B Perryman; S A Kerner; T J Bohlmeyer; R Roberts
Journal:  Biochem Biophys Res Commun       Date:  1986-11-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.